期刊
BIOMEDICINE & PHARMACOTHERAPY
卷 149, 期 -, 页码 -出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2022.112812
关键词
Traumatic; Brain Injury; Concussion; Parkinson's disease; Parkinsonism; Neurodegeneration; CNS Delivery
资金
- National Insti-tute of Neurological Disorders and Stroke of the National Institutes of Health [R01 NS108968-01]
The clinical translation of therapeutic approaches for treating neurodegenerative conditions such as Parkinson's disease remains a pressing challenge. Recent research has focused on the connection between traumatic brain injury and Parkinson's disease, identifying common targets for the development of more effective treatments. This review provides a detailed background on the pathophysiology of traumatic brain injury and its overlap with Parkinson's disease, with emphasis on their impact on perivascular clearance.
The clinical translation of therapeutic approaches to combat debilitating neurodegenerative conditions, such as Parkinson's disease (PD), remains as an urgent unmet challenge. The strong molecular association between the pathogenesis of traumatic brain injury (TBI) and the development of parkinsonism in humans has been well established. Therefore, a lot of ongoing research aims to investigate this pathology overlap in-depth, to exploit the common targets of TBI and PD for development of more effective and long-term treatment strategies. This review article intends to provide a detailed background on TBI pathophysiology and its established overlap with PD with an additional emphasis on the recent findings about their effect on perivascular clearance. Although, the traditional animal models of TBI and PD are still being considered, there is a huge focus on the development of combinatory hybrid animal models coupling concussion with the pre-established PD models for a better recapitulation of the human context of PD pathogenesis. Lastly, the therapeutic targets for TBI and PD, and the contemporary research involving exosomes, DNA vaccines, miRNA, gene therapy and gene editing for the development of potential candidates are discussed, along with the recent development of lesser invasive and promising central nervous system (CNS) drug delivery strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据